Workflow
诺思格:2025一季报净利润0.26亿 同比增长13.04%
301333R&G PharmaStudies (301333) 同花顺财报·2025-04-27 08:37

Financial Data and Indicators - The basic earnings per share for Q1 2025 is 0.2700 CNY, representing a 12.5% increase compared to Q1 2024, which was 0.2400 CNY [1] - The net profit for Q1 2025 is 0.26 billion CNY, showing a 13.04% increase from Q1 2024's 0.23 billion CNY [1] - The return on equity for Q1 2025 is 1.41%, up 7.63% from 1.31% in Q1 2024 [1] - The total operating revenue for Q1 2025 is 1.73 billion CNY, a decrease of 2.26% from 1.77 billion CNY in Q1 2024 [1] Shareholder Information - The top ten unrestricted shareholders hold a total of 32.574 million shares, accounting for 57.02% of the circulating shares, with a decrease of 3.1175 million shares compared to the previous period [2] - Ningbo Kangyunfu Equity Investment Co., Ltd. holds 11.52 million shares, representing 20.16% of the total share capital, with no change [2] - The E Fund Healthcare Industry Mixed A fund has reduced its holdings by 549,400 shares, now holding 3.7355 million shares, which is 6.54% of the total [2] Dividend Distribution - The company will not distribute or transfer any dividends this time [3]